It is well known that plasminogen activator in blood plays an important role in endogenous fibrinolysis by converting plasminogen to plasmin. Thus, stimulation of endogenous fibrinolysis by a pharmaceutical agent may be useful for prevention and treatment of patients with thrombosis. Since vascular endothelial cells synthesize and secrete plasminogen activator, cultured endothelial cells are suitable for the study of the modulation of endogenous fibrinolytic activity in an in vitro system. 1-4) It has been reported that physiological substances such as thrombin, 5,6) short-chain fatty acids 7) and retinoids 8, 9) induce an increase in the fibrinolytic activity in cultured endothelial cells via enhancement of plasminogen activator synthesis. Of these, we have been interested in retinoids because the inducing activity of plasminogen activator synthesis could easily be improved by chemical modification of its conjugated polyene functionality.
It is well known that plasminogen activator in blood plays an important role in endogenous fibrinolysis by converting plasminogen to plasmin. Thus, stimulation of endogenous fibrinolysis by a pharmaceutical agent may be useful for prevention and treatment of patients with thrombosis. Since vascular endothelial cells synthesize and secrete plasminogen activator, cultured endothelial cells are suitable for the study of the modulation of endogenous fibrinolytic activity in an in vitro system. [1] [2] [3] [4] It has been reported that physiological substances such as thrombin, 5, 6) short-chain fatty acids 7) and retinoids 8, 9) induce an increase in the fibrinolytic activity in cultured endothelial cells via enhancement of plasminogen activator synthesis. Of these, we have been interested in retinoids because the inducing activity of plasminogen activator synthesis could easily be improved by chemical modification of its conjugated polyene functionality.
We performed random screening of polyene compounds in Tanabe libraries and found that (3E,4E)-3,4-dibenzylidenepyrrolidine-2,5-dione (1a) showed high potency of plasminogen activator induction (Fig. 1) . We selected 1a as the lead compound, and carried out its chemical modification to enhance the activity. In this paper, we describe stereoselective syntheses, structure-activity relationships (SAR), and antithrombotic activities of 1,4-diphenylbutadiene derivatives.
Chemistry
The typical synthetic route of the succinimide type derivatives of 1,4-diphenylbutadiene 1a-r is shown in Chart 1. The key intermediate (E,E)-dibenzylidenesuccinic acid monomethyl esters 14a-c were synthesized utilizing twice the Stobbe condensation. 10) The (E)-benzylidenesuccinic acid methyl ester obtained stereoselectively in the first Stobbe condensation of benzaldehyde 12a, b with dimethyl succinate, 11) was transformed into the (E)-dimethyl esters 13a, b by treatment with a catalytic amount of c.H 2 SO 4 in MeOH. The second Stobbe condensation of 13a, b with benzaldehyde or 3,4,5-trimethoxybenzaldehyde, steroselectively afforded the (E,E)-half-esters 14a-c. Treatment of 14a-c with SOCl 2 followed by excess aqueous NH 3 afforded the imide derivatives 1a, g. The intermediate succinamate 2 was spontaneously cyclized to succinimide 1 in this reaction condition because of the basicity of ammonia. The Stobbe condensation of 13a, b with substituted benzaldehyde and successive amidation with ammonia afforded the imide derivatives 1b-f, 1h-m. Instead of ammonia, various amines were used to afford N-substituted succinimide derivatives 1n-r from 14b. The syntheses of the succinamate type derivatives 2a-k were performed by treatment of equimolar ammonia or amine and at low reaction temperature.
The syntheses of the (E,E)-dibenzylidenesuccinic anhydride 3, (E,E)-dibenzylidene-g-butyrolactone 4a, b and (E,E)-dibenzylidene-g-butyrolactam 5a, b are shown in Chart 2. The anhydride 3 was obtained by treatment of halfester 14b with SOCl 2 and SnCl 4 successively. The half-ester 14b, c was reduced with diisobutylaluminum hydride (DIBAL-H) to give the corresponding alcohol, which was successively treated with aqueous HCl to afford the lactone 4a, b. Treatment of amide 2b, c with PPh 3 and CCl 4 afforded the nitrile 15a, b. Hydrogenation of the nitrile 15a, b in the presence of Raney-Ni followed by cyclization by heating afforded the lactam 5a, b.
In order to explore the effect of stereochemistry on butadiene moiety, we decided to synthesize all isomers of 1g and 2b, which possessed a high potency of t-PA induction. The stereoisomers of dibenzylidenesuccinimide 1g and methyl dibenzylidenesuccinamate 2b were synthesized by utilizing a cross-coupling reaction 12) as a key step, as shown in Chart 3. 17) with retention of the configuration in high yields. The stannannes 25, 26 were synthesized in a similar manner. Lithiation of phenylacetylene (23) followed by bubbling of carbon dioxide afforded the propiolic acid, which was converted to the amide 24. Hydrostannation of the propiolic amide 24 in the presence of Pd(PPh 3 ) 4 or AIBN afforded (E)-vinylstannane 25 or (Z)-vinylstannane 26 steroselectively. The crosscoupling reaction of the (Z)-vinylbromide 22 with the (E)-vinylstannane 25 smoothly proceeded in the presence of Pd(PPh 3 ) 2 Cl 2 in DMF at 60°C 18) to provided the (E,Z)-amide 9. The (E,Z)-imide 6 was obtained in high yield by treatment of 9 with aqueous NaOH. Similarly, the appropriate combination of the (E)-vinylbromide 21 and the (Z)-vinylstannane 26 gave the corresponding (Z,E)-amide 10 and (Z,E)-imide 7. Next, the (Z,Z)-amide 11 and (Z,Z)-imide 8 was obtained from the (E)-vinylbromide 21 and the (E)-vinylstannane 25.
Biological Result and Discussion
To determine whether the synthesized compounds can stimulate the fibrinolytic activity in vascular endothelial cells, the cells were treated with the compounds for 24 h, and the activity of the plasminogen activator (PA) in the conditioned medium was measured. Table 1 summarizes the relative PA activity of vascular endothelial cells treated with dibenzylidenesuccinimide derivatives 1a-r, compared to the control cells treated with vehicle alone. First, the effect of the electron-withdrawing (1b, c) and electron-donating (1d-g) substituents R 1 of the dibenzylidenesuccinimide was examined. Among the compounds 1b-g, the 3,4,5-trimethoxy-substituted derivative 1g was revealed to possess good potency of the PA activity. Next, the effect of the electron-withdrawing (1h, i) and electron-donating (1j-m) substituents R 2 in 1g was examined. All of the R 2 -substituted derivatives 1h-m exhibited much lower activity than 1g. Finally, the effect of the N-substituents R 3 in 1g was examined. As a result, all of the R 3 -substituted derivatives 1n-r exhibited much lower activity than 1g. Table 2 summarizes the relative PA activity of dibenzylidenesuccinamate derivatives 2a-k compared to the control cells treated with vehicle alone. First, the 3,4,5-trimethoxysubstituted derivatives 2b, c were examined due to effective substituent in dibenzylidenesuccinimide derivatives. The R 2 -substituted derivative 2b was revealed to possess equal potency with the dibenzylidenesuccinimide derivative 1g. However, the R 1 -substituted derivative 2c was revealed to be less potent than 1g. Next, the effect of substituents R 1 in 2b was examined. All of the R 1 -substituted derivatives 2d-f exhibited much lower activity than 2b. Finally, the effect of the Nsubstituents R 3 in 2b was examined. Among the compounds of 2g-k, the methyl-substituted derivative 2g and the amino-substituted derivative 2j were revealed to possess good potency of the PA activity. However, the potency did not exceed 2b. These results suggest that a small substituent in R 3 is particularly favorable for good potency. As shown in Table 3 , the effect of the other ring derivatives was examined. The anhydride 3 and the lactams 5a, b exhibited much lower activity than 1g, whereas the lactones 4a, b possessed the good potency of the PA activity. In particular, 4a exhibited much higher activity than 1g.
The activity of stereoisomers in 1g and 2b are summarized in Table 4 . Both succinimide derivatives 6-8 and succinamate derivatives 9-11 showed no strong activity. These results show that the E,E-isomer is most effective.
In the compounds that showed strong activity, 1g, 2b and 4a were evaluated the antithrombotic activity in a rat model of venous thrombosis (Table 5 ). In this model, the antithrombotic activity of 1g was more potent than that of 2b and 4a.
Conclusion
On the basis of modification conjugated polyene functionality in retinoid, we have prepared 1,4-diphenylbutadiene derivatives to obtain a compound with plasminogen activator inducing activity. After identifying the optimum substituent on the two phenyl rings of dibenzylidenesuccinimide 1a, various modifications to the N-substituent, the ring system, and the stereochemistry of double bonds have been investigated. Among the series of compounds obtained, we selected 1g (T-686) for further evaluation as an antithrombotic agent. Experimental Melting points were measured using a Büchi 535 capillary melting point apparatus and are uncorrected. IR spectra were recorded on a Perkin-Elmer 1640 infrared spectrophotometer.
1 H-NMR spectra were recorded on a Bruker AC-200 spectrometer with Me 4 Si as an internal standard. Mass spectra were recorded on a Hitachi M-2000A spectrometer at 70eV, and high-resolution mass spectra (HR-MS) were measured with a JEOL JMS HX-100 spectrometer. Elemental analyses were carried out in this laboratory. Silica gel (Kieselgel 60, Merck) was used for column chromatography, and silica gel (Kieselgel 60 F 254 , layer thickness 0.25 mm, Merck) for analytical thin layer chromatography (TLC).
Dimethyl (E)-2-Benzylidenesuccinate (13a) A solution of benzaldehyde (15.9 g, 0.15 mol) and dimethyl succinate (26.3 g, 0.18 mol) in tertBuOH (20 ml) was added to a solution of potassium tert-butoxide (16.8 g, 0.15 mol) in tert-BuOH (150 ml) below 50°C and the mixture was stirred at room temperature for 30 min. The reaction mixture was poured into icewater and the aqueous layer was washed with i-Pr 2 O and acidified with c.HCl. The organic layer was extracted with AcOEt and washed with brine, dried (MgSO 4 ), and concentrated in vacuo. The residue was dissolved in MeOH (75 ml). To this solution was added c.H 2 SO 4 (0.75 ml) and the mixture was refluxed for 5 h. After the removal of solvent, saturated aqueous NaHCO 3 was added and the mixture was extracted with AcOEt. The organic layer was washed with brine, dried (MgSO 4 ), and concentrated in vacuo. The residue was chromatographed on silica gel. Elution with hexane/AcOEt (4 : 1) gave 13a (23.2 g, 66%) as an oil. (3E,4E)-3,4-Dibenzylidenepyrrolidine-2,5-dione (1a) To a solution of 14a (8.1 g, 26 mmol) in CHCl 3 (40 ml) were added SOCl 2 (1.9 ml, 26 mmol) and DMF (2 drops) below 10°C and the mixture was refluxed for 30 min. This solutuon was added to 28% aqueous NH 3 (10 ml) and the mixture was stirred at room temperature for 1 h. To this solution, 2 N HCl was added to pH 7 and the mixture was extracted with CHCl 3 and dried (MgSO 4 ), and concentrated in vacuo. The residue was crystalized in AcOEt to give 1a (4.4 g, 79% 
Methyl (2E,3E )-2-Benzylidene-3-carbamoyl-4-phenylbut-3-enoate (2a)
To a solution of 14a (4.0 g, 13 mmol) in CHCl 3 (50 ml) were added SOCl 2 (1.0 ml, 13 mmol) and DMF (2 drops) below 10°C and the mixture was refluxed for 30 min. This solutuon was added dropwise to 28% aqueous NH 3 (0.8 ml, 13 mmol) below 0°C and the mixture was stirred at same temperature for 30 min. The organic layer was extracted with CHCl 3 The following compounds (2b-k) were prepared from the corresponding half-ester (14a-c) or diester (13a, b) by a method similar to that described for 2a. (3E,4E )-3-Benzylidene-4-(3,4,5-trimethoxybenzylidene)-dihydrofuran-2,5-dione (3) To a solution of 14b (7.3 g, 18 mmol) in toluene (50 ml) were added SOCl 2 (1.3 ml, 18 mmol) and DMF (1 drop) and the mixture was stirred at 80°C for 30 min. To this solutuon, SnCl 4 (2.7 ml, 23 mmol) was added below 10°C and the mixture was stirred at room temperature for 16 h. The reaction mixture was poured into ice-water and the organic layer was extracted with AcOEt and washed with 1 N NaOH and brine, dried (MgSO 4 ), and concentrated in vacuo. The residue was crystalized in Et 2 O to give 3 (4.8 g, 72%). mp 201-203°C. (3E,4E )-3-Benzylidene-4-(3,4,5-trimethoxybenzylidene)-dihydrofuran-2-one (4a) To a solution of 14b (5.0 g, 13 mmol) in CH 2 Cl 2 (50 ml) was added 1.5 M diisobutylaluminum hydride in toluene (25 ml, 38 mmol) under nitrogen below 10°C and the mixture was stirred at room temperature for 1 h. To this solution, 10% aqueous HCl was added carefully until pH 1 below 10°C and the mixture was stirred at 50°C for 1 h. The organic layer was extracted with CHCl 3 and dried (MgSO 4 ), and concentrated in vacuo. The residue was chromatographed on silica gel (hexane : AcOEtϭ2 : 1) to give 4a (2.3 g, 53%); mp 145-146°C. Methyl (2E,3E )-3-Cyano-4-phenyl-2-(3,4,5-trimethoxybenzylidene) (10 g, 28 mmol) in dry THF (100 ml) was added n-butyllithium (1.6 M in hexane) (39 ml, 63 mmol) below Ϫ50°C under nitrogen and the mixture was stirred at room temperature for 1 h. Then methyl chloroformate (2.6 ml, 34 mmol) in dry THF (20 ml) was added below Ϫ50°C and the resulting mixture was stirred at room temperature for 30 min. The reaction was quenched by addition of saturated aqueous NH 4 Cl and the reaction mixture was extracted with AcOEt. The organic layer was washed with brine, dried (MgSO 4 ), and concentrated in vacuo. The residue was chromatographed on silica gel (hexane : AcOEtϭ3 : 1) to give 18 (6.3 g, 88%); mp 97-98°C. 3-Phenylpropiolamide (24) To a solution of phenylacetylene (5.0 g, 49 mmol) in dry THF (100 ml) was added n-butyllithium (1.6 M in hexane) (34 ml, 54 mmol) below Ϫ50°C under nitrogen and the mixture was stirred at Ϫ78°C for 30 min. Then CO 2 gas was bubbled below 0°C for 30 min. The reaction mixture was acidified to pH 1 with 10% aqueous HCl and extracted with CHCl 3 . The organic layer was washed with brine, dried (MgSO 4 ), and concentrated in vacuo. The residue was dissolved in CHCl 3 (50 ml). To this solution was added SOCl 2 (4.3 ml, 59 mmol) and DMF (2 drops) and the mixture was stirred at room temperature for 1 h. This solution was added to 28% aqueous NH 3 (20 ml) below 10°C and the mixture was stirred at room temperature for 30 min. The organic layer was extracted with AcOEt and aqueous KF was added to the residue and the mixture was stirred for 1 h. The insoluble material was filtered off and the filtrate was extracted with AcOEt. The organic layer was washed with brine, dried (MgSO 4 ), and concentrated in vacuo. The residue was chromatographed on silica gel (CHCl 3 : acetoneϭ5 : 1) to give 9 (3.1 g, 63%); mp 146-147°C. 1 (3Z,4E )-3-Benzylidene-4-(3,4,5-trimethoxybenzylidene)-pyrrolidine-2,5-dione (6) To a solution of 9 (2.0 g, 5.0 mmol) in THF (20 ml) was added 2 N NaOH (5 ml) and the mixture was stirreded for 30 min. To this solution, 2 N HCl (5 ml) was added and the mixture was extracted with CHCl 3 and dried (MgSO 4 ), and concentrated in vacuo. The residue was chromatographed on silica gel (CHCl 3 : acetoneϭ10 : 1) to give 6 (1.7 g, 93%); mp 176-178°C. 
Methyl (2E,3E )-3-Carbamoyl-4-phenyl-2-(3,4,5-trimethoxybenzylidene)-but-3-enoate (2b)
Yield
